Clinical Trial Update: T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating T-cell depleted allogeneic stem cell transplantation for hematologic malignancies; study is completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Aplastic Anemia
• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Myelodysplastic Syndromes
• Myelogenous Leukemia
• Myeloproliferative Neoplasms
• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Chicago | Conditions: Acute Myelogenous Leukemia, Lymphoid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2014-03-31